Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Dry needling to help MS-related leg pain and walking

Official title: Non-pharmacological Management of Chronic Pain in Persons With Multiple Sclerosis

Run by University of South Florida · NCT07615725 · Data updated 2026-11-12

This study tests whether dry needling can lessen chronic leg pain and improve balance and walking in adults with multiple sclerosis.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of South Florida
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Tampa, Florida)
StatusRecruiting
StartedMay 8, 2026
Main results expectedMay 1, 2027
Study endsJune 1, 2027
Registry record updatedOctober 29, 2026
Trial IDNCT07615725 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-80 with MS, ambulatory (PDDS 1-5), and chronic lower-extremity pain (NPRS ≥3 for at least 3 months).

Probably not a fit

Individuals with recent MS relapse, other neurological conditions, or planned changes in pain medications may not benefit or may be excluded from potential gains.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers at the University of South Florida will compare dry needling with sham dry needling in adults with multiple sclerosis who have chronic lower-extremity pain. The goal is to see if targeted muscle needling reduces pain and improves balance and walking ability. Participants will be adults aged 18 to 80 with MS, ambulatory, and pain lasting at least 3 months. The trial uses two groups and follows standard clinical research procedures to minimize bias. Outcomes will inform whether dry needling could be a non-pharmacologic option for MS-related lower-extremity symptoms.

Why it matters

Potential benefit: If successful, participants may experience reduced leg pain and better mobility without added medications.

How similar studies have gone: Dry needling and sham-controlled approaches have shown potential in managing musculoskeletal pain in various conditions, but evidence specifically in MS-related leg pain is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\*

* Diagnosis of Multiple Sclerosis (MS) based on the McDonald criteria
* Patient Determined Disease Steps (PDDS) score of 1-5 (ambulatory participants)
* Ability to communicate in written and spoken English
* Age 18-80 years
* Chronic lower-extremity pain lasting more than three consecutive months, with a pain intensity of at least 3 out of 10 on the Numeric Pain Rating Scale (NPRS)

\*\*Exclusion Criteria:\*\*

* Any neurological comorbidity (e.g., stroke or Parkinson's disease)
* MS relapse within the past 30 days
* Current participation in or planned initiation of any pain management intervention (interventional or rehabilitative) targeting the lower extremity
* Anticipated changes in pain medication during the study period
* Pregnancy, as determined by a urine pregnancy test
* Active cancer or chemotherapy within the past year
* Montreal Cognitive Assessment (MoCA) score below 17
* Known or suspected infection in the lower extremity
* Deep vein thrombosis
* Thrombophlebitis
* Active osteomyelitis in the lower extremity
* Varicose veins
* Uncontrolled seizures or epilepsy

Where it's running

  • University of South Florida
    Tampa, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.